MAPK9 and prostate carcinoma: Gossypol also inhibits growth of prostate cancer cells by modulation of TGF beta/Akt signaling [22], activates p53 to induce apoptosis in prostate cancer cells [23], and enhances radiation-induced apoptosis through SAPK/JNK pathway [24].